Sunesis Pharmaceuticals, Inc. (SNSS) Reaches $4.25 After 6.00% Up Move; Caisse De Depot Et Placement Du Quebec Has Trimmed Costar Group (CSGP) Stake

January 14, 2018 - By Darrin Black

The stock of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) is a huge mover today! The stock increased 5.99% or $0.24 during the last trading session, reaching $4.25. About 138,920 shares traded. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) has risen 8.33% since January 14, 2017 and is uptrending. It has underperformed by 8.37% the S&P500.The move comes after 9 months positive chart setup for the $145.56M company. It was reported on Jan, 14 by Barchart.com. We have $4.51 PT which if reached, will make NASDAQ:SNSS worth $8.73M more.

Caisse De Depot Et Placement Du Quebec decreased Costar Group Inc (CSGP) stake by 52% reported in 2017Q3 SEC filing. Caisse De Depot Et Placement Du Quebec sold 1,560 shares as Costar Group Inc (CSGP)’s stock rose 21.01%. The Caisse De Depot Et Placement Du Quebec holds 1,440 shares with $388,000 value, down from 3,000 last quarter. Costar Group Inc now has $11.64B valuation. The stock increased 1.48% or $4.71 during the last trading session, reaching $322.02. About 239,441 shares traded or 8.87% up from the average. CoStar Group, Inc. (NASDAQ:CSGP) has risen 29.48% since January 14, 2017 and is uptrending. It has outperformed by 12.78% the S&P500.

Among 5 analysts covering Sunesis Pharmaceuticals (NASDAQ:SNSS), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Sunesis Pharmaceuticals had 11 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Sell” rating by TH Capital given on Friday, July 24. The firm has “Hold” rating by Cantor Fitzgerald given on Tuesday, July 18. The rating was maintained by Cantor Fitzgerald on Thursday, July 27 with “Hold”. The company was downgraded on Friday, July 24 by Cantor Fitzgerald. The stock of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) earned “Outperform” rating by Wells Fargo on Friday, July 29. The company was downgraded on Friday, July 24 by Cowen & Co. On Tuesday, December 5 the stock rating was downgraded by Wells Fargo to “Market Perform”. On Monday, November 20 the stock rating was initiated by Oppenheimer with “Buy”. The rating was initiated by Oppenheimer on Thursday, December 14 with “Buy”. The rating was upgraded by Wells Fargo on Monday, December 11 to “Buy”.

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The company has market cap of $145.56 million. The firm is developing vosaroxin, an anticancer quinolone derivative for the treatment of acute myeloid leukemia . It currently has negative earnings. It has completed a Phase III, randomized, double-blind, and placebo-controlled trial of vosaroxin in combination with cytarabine in patients with relapsed or refractory AML.

Analysts await Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) to report earnings on March, 8. They expect $-0.25 earnings per share, up 43.18% or $0.19 from last year’s $-0.44 per share. After $-0.43 actual earnings per share reported by Sunesis Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -41.86% EPS growth.

Analysts await CoStar Group, Inc. (NASDAQ:CSGP) to report earnings on February, 28. They expect $1.21 earnings per share, up 9.01% or $0.10 from last year’s $1.11 per share. CSGP’s profit will be $43.74M for 66.53 P/E if the $1.21 EPS becomes a reality. After $1.23 actual earnings per share reported by CoStar Group, Inc. for the previous quarter, Wall Street now forecasts -1.63% negative EPS growth.

Investors sentiment increased to 1.42 in Q3 2017. Its up 0.32, from 1.1 in 2017Q2. It is positive, as 19 investors sold CSGP shares while 88 reduced holdings. 57 funds opened positions while 95 raised stakes. 33.56 million shares or 9.65% more from 30.60 million shares in 2017Q2 were reported. Prudential Inc accumulated 39,427 shares or 0.02% of the stock. Df Dent Company Incorporated has invested 2.3% in CoStar Group, Inc. (NASDAQ:CSGP). Moreover, Credit Agricole S A has 0% invested in CoStar Group, Inc. (NASDAQ:CSGP). Segall Bryant And Hamill Lc holds 0.09% of its portfolio in CoStar Group, Inc. (NASDAQ:CSGP) for 15,153 shares. Utd Cap Fincl Advisers Limited Liability holds 0.01% in CoStar Group, Inc. (NASDAQ:CSGP) or 3,291 shares. Macquarie Group Ltd invested in 0.01% or 10,652 shares. State Street Corporation holds 0.01% or 580,064 shares. First Advsr LP reported 89,118 shares. Brinker reported 3,952 shares or 0.04% of all its holdings. Gideon Capital Advsr owns 1,386 shares. Winslow Mgmt Limited has invested 1.05% in CoStar Group, Inc. (NASDAQ:CSGP). Gotham Asset Management Ltd Liability Corporation holds 0.02% in CoStar Group, Inc. (NASDAQ:CSGP) or 5,738 shares. Pitcairn reported 987 shares. Amp Capital Investors Ltd holds 6,756 shares or 0.01% of its portfolio. Stevens Capital Mgmt Lp holds 0.14% or 13,743 shares in its portfolio.

Among 9 analysts covering CoStar Group (NASDAQ:CSGP), 8 have Buy rating, 1 Sell and 0 Hold. Therefore 89% are positive. CoStar Group had 16 analyst reports since August 12, 2015 according to SRatingsIntel. SunTrust maintained it with “Buy” rating and $335.0 target in Thursday, October 26 report. On Thursday, October 5 the stock rating was maintained by Bank of America with “Buy”. The company was initiated on Monday, August 22 by Needham. J.P. Morgan downgraded it to “Sell” rating and $325.0 target in Tuesday, December 12 report. Zacks downgraded the shares of CSGP in report on Wednesday, August 12 to “Hold” rating. The rating was initiated by Citigroup with “Buy” on Tuesday, December 20. The rating was maintained by Needham on Thursday, October 26 with “Buy”. The firm has “Buy” rating given on Friday, October 20 by SunTrust.

Caisse De Depot Et Placement Du Quebec increased Pembina Pipeline Corp (NYSE:PBA) stake by 25,800 shares to 8.50 million valued at $298.70M in 2017Q3. It also upped Yy Inc (NASDAQ:YY) stake by 43,200 shares and now owns 70,119 shares. Abbvie Inc (NYSE:ABBV) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>